Fund Benefits From Weave Bio Platform Launch and 40% AUM Growth
GTLL•Weave Bio activated single-source global filing platform for IND, CTA and NDA applications. Apollo’s fee-generating AUM rose 40% to $836 billion and Tap Earn AUM climbed 43% to $5 million, while CI ETFs declared June distributions and Novatus Global named Andrew Pinnington as CCO.
1. Regulatory Platform Launch
Weave Bio rolled out new global submission capabilities, enabling drug development teams to submit IND, CTA and NDA filings from a single platform, enhancing regulatory automation and streamlining documentation for the fund’s biotech holdings.
2. Asset Manager Growth
Among the fund’s financial sector assets, Apollo Global Management’s fee-generating AUM increased 40% year-over-year to $836 billion, while Tap Global’s Tap Earn product AUM grew 43% to over $5 million, reflecting robust capital inflows despite cryptocurrency market volatility.
3. Income Distributions
CI Global Asset Management’s ETFs declared regular cash distributions for periods ending June 30, supporting the fund’s income strategy with additional yield generated by equity and fixed-income allocations.
4. Leadership Appointment
Novatus Global strengthened its executive bench by appointing Andrew Pinnington as Chief Customer Officer, following its $40 million growth investment, signaling a focus on client relationships for its regulatory technology services.
